Shots:
- The US FDA has approved Deseyne (vifilcon C) daily disposable contact lens with FusionTechnology; commercially available in Q4’25
- Deseyne lenses integrates 2 patented innovations: vifilcon C hydrogel material & FusionTechnology, to gradually release embedded Lachryceuticals (incl. amino acids, vitamins, & polysaccharides), ensuring sustained bioavailability & long-lasting eye comfort
- FusionTechnology combines hyaluronic acid & tamarind seed polysaccharides to form a tear-like bio-copolymer that steadily releases with body temperature, blinking, & eyelid pressure to improve hydration, comfort, & stability
Ref: Businesswire | Image: Bruno Vision Care
Related News:- Innoblative Secures the US FDA’s IDE Approval of SIRA Electrosurgical Device for Breast Cancer Patients
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
